← All claims

Metabolic & Cardiometabolic

beta-glucan decreases postprandial glucose

In plain terms: Does oat fibre lower the blood-sugar spike after a meal?

Strong support Metabolic & Cardiometabolic 🔬 Includes disconfirming

Part of: 🧪 beta-glucan

RefutedContestedStrong support
consensus score 0.80

Yes — well-established, but only if the fibre is intact and not over-processed.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

14 support 0 contradict 2 tested null 4 mixed · 20 sources, 14 independent groups · 1 superseded — pooled inside a review, counted once

What the evidence shows

Oat/barley beta-glucan lowers postprandial glucose & insulin in a dose- and molecular-weight-dependent way; the effect vanishes below ~300 kg/mol MW.

The evidence (25)

SourceGradeStanceQualityFinding
Tosh SM, Bordenave N
2020 · Nutr Rev
in-vitro supports high Narrative review: 'The aim of this work is to review the major mechanisms by which consumption of whole grain oats and barley, and β-glucans, reduces the risk of coronary heart disease, type 2 diabetes'; discusses viscosity and processing effects on postprandial glucose. No new data or pooling — review, zero weight.
Alhuwaymil A, Alfheeaid HA, Algeffari M, Barakat H
2026 · Frontiers in Nutrition
RCT supports moderate n=20 healthy + 20 T2D adults; oat-fiber-enriched (7.5%) low-calorie date snacks significantly blunted postprandial glucose excursions at 30-120min vs control snack in both groups (psyllium variant slightly superior to oat).
Marcobal AM, Ng KM, Drexler RA, McConnell BR, Amicucci MJ
2026 · Frontiers in nutrition
observational supports low 14-day open-label pilot, n=63 (CGM subgroup n=38); short-chain (low-viscosity, degraded) oat β-glucan fiber at 10-20g/day reduced peak glucose and improved CGM glycemic metrics, but was engineered for LOW viscosity/improved solubility, no p
Rieder A, Knutsen SH, Sainz Fernandez A, Ballance S
2019 · Food Funct
RCT supports moderate 3.8g/serving cut peak/iAUC/GI regardless of MW; 1.7g worked only at high MW
↩ SUPERSEDED — pooled in the review above, counted once
EFSA Panel on Nutrition et al
2026 · EFSA journal. European Food Safety Authority
meta-analysis supports high EFSA panel opinion weighing 16 human intervention studies on oat beta-glucan (OBG); most studies showed OBG reduces postprandial glucose peak when consumed with ≥30g avCHO meals at ≥3g BG/30g avCHO, without raising insulinaemic response.
Thondre PS, Henry CJ
2011 · Int J Food Sci Nutr
RCT tested-null moderate Low molecular weight barley beta-glucan (75% purity) did NOT lower glycemic response of chapattis.
Hu J, Fan Z, Wei J, Peng X, Zhu Q, Liu R, Lou X, Xing Y
2026 · Food research international (Ottawa, Ont.)
RCT supports moderate Randomized crossover, n=21 healthy young women; low-temperature roasted oat paste (preserving β-glucan integrity/viscosity) elicited significantly lower postprandial glucose than high-temperature roasted oat paste or refined rice control.
Aldughpassi A, Abdel-Aal el-SM, Wolever TM
2012 · J Nutr
RCT mixed moderate Barley GI varied by cultivar/processing but not predicted by beta-glucan or amylose content.
Poppitt SD, van Drunen JD, McGill AT, Mulvey TB, Leahy FE
2007 · Asia Pac J Clin Nutr
RCT mixed moderate Barley beta-glucan blunted glycemia in solid food but not beverage; viscosity/matrix dependent.
Thondre PS, Henry CJ
2009 · Nutr Res
RCT supports moderate Barley beta-glucan in chapatis dose-dependently lowered glycemic index in healthy subjects
Nematizadeh M, Babaei A, Nikbakht-Jam I, Elahikhah M, Mohammadi-Sartang M
2026 · Nutrition reviews
meta-analysis supports high Meta-analysis of 31 controlled trials (34 arms, 660 vs 665 participants); barley (β-glucan-rich) supplementation significantly reduced postprandial glucose at 30/60/120 min (e.g. -12.38 mg/dL at 60min) though not at 180min or for fasting gl
Zurbau A, Noronha JC, Khan TA, Sievenpiper JL, Wolever TMS
2021 · J Nutr
meta-analysis supports high FT 103 comparisons iAUC -23% dose-response; CAVEAT MW>300kg/mol required, degraded BG inactive
Ames N, Blewett H, Storsley J, Thandapilly SJ, Zahradka P, Taylor C
2015 · Br J Nutr
RCT supports moderate High-beta-glucan barley tortillas elicited lower glucose and insulin response than low-beta-glucan.
d10-1051-bioconf-202624105002-pdf
2026 · Springer Link (Chiba Institute of Technology)
observational supports low Narrative mini-review on overnight-soaked oats; states beneficial effects are attributed to increased β-glucan viscosity slowing gastric emptying and attenuating postprandial glucose/insulin peaks, citing a meta-analysis on LDL (3g/day, 5-1
Kellogg JA, Monsivais P, Murphy KM, Perrigue MM
2025 · Nutrients
RCT supports moderate High beta-glucan whole grain barley reduced postprandial glycemic response vs control in healthy adults.
Hajnal F, Florina R, Călin A, Simona TF, Mihai G
2026 · Nutrients
observational supports low Narrative review of clinical trials/meta-analyses on soluble fibers (including β-glucan) in T2D; states beta-glucan and other soluble fibers have demonstrated beneficial effects on glycemia and HbA1c via colonic fermentation/SCFA mechanisms
Liljeberg HG, Granfeldt YE, Björck IM
1996 · J Nutr
RCT mixed moderate High-fiber barley genotype lowered glucose/insulin but common barley and oats did not vs wheat reference.
Panahi S, Ezatagha A, Jovanovski E, Jenkins A, Temelli F, Vasanthan T, Vuksan V
2014 · J Am Coll Nutr
RCT tested-null moderate Randomised crossover, n=12 healthy adults: snack bars with 0, 1.5, 3 or 6 g oat or barley beta-glucan (50 g available carbohydrate each; top dose = 3.6 g/30 g avCHO) vs white bread. 'Incorporation of 1.5 to 6 g of β-glucan into snack bars had no additional glucose-lowering benefits irrespective of dose and source compared to the control bars (0 g β-glucan)'; all bars incl. the 0 g bar cut glucose AUC ~25% vs white bread (bar matrix, not beta-glucan). Null at doses below the claim's >=4 g/30 g avCHO scope threshold; MW not reported in abstract. Abstract-only.
Kim IS, Park SY, Park MJ, Kim KJ, Kim JY
2024 · Nutrients
RCT supports high Randomized, double-blind, placebo-controlled crossover, n=67 healthy adults; β-glucan-rich barley dietary fiber (BDF) significantly delayed/reduced the postprandial blood glucose rise and reduced insulin secretion vs rice-flour placebo.
Sasaki H, Matsumoto Y, Masutomi H, Ishihara K, Hirao K, Shibata S, Furutani A
2026 · Food science & nutrition
RCT supports low Randomized crossover, n=11 (Exp.1)/10 (Exp.2), healthy Japanese adults; all oat-based (β-glucan-containing) foods reduced postprandial blood glucose vs white rice, with cooked oats also suppressing the second-meal glucose rise.
Caferoglu Z, Aytekin Sahin G, Gonulalan Z, Hatipoglu N
2022 · Food Funct
RCT supports moderate Crossover RCT: barley and oat beta-glucan bread lowered postprandial glycaemia vs white/whole-wheat bread
Mathews R, Chu Y
2024 · Crit Rev Food Sci Nutr
meta-analysis supports high Overview of syntheses: 'The purpose of this review was to critically evaluate the state of the science of oats ... from meta-analyses and systematic reviews.' Reports oat RCTs 'demonstrated a significant reduction in postprandial blood glucose in both diabetic and non-diabetic subjects'. Oats, not isolated beta-glucan. Review — zero weight.
Kang I, Jang H, Gim M, Bae SE, Lee YJ, Leem CS, Park YK
2025 · Nutrients
RCT mixed low Barley-based cereals enhanced metabolic health and satiety in overweight Korean adults.
Nilsson AC, Ostman EM, Holst JJ, Björck IM
2008 · J Nutr
RCT supports moderate Barley-kernel/beta-glucan evening meals improved next-morning glucose tolerance via colonic fermentation.
Chu Z, Ran H, Zhang H, Su Q
2025 · Asia Pacific journal of clinical nutrition
RCT supports moderate Randomized crossover, n=10 healthy adults; highland barley-multigrain rice (containing barley β-glucan) had significantly lower iAUC and peak glucose change than white rice at equal 50g avCHO.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.